Filter
7927
Filtered Results: 7927
Text search:
infetion
control
Featured
Recommendations
861
New Publications
1997
Language
Document type
No document type
4093
Guidelines
1399
Studies & Reports
1112
Manuals
374
Fact sheets
279
Strategic & Response Plan
263
Training Material
131
Situation Updates
84
Infographics
68
Online Courses
35
Resource Platforms
31
Videos
30
Brochures
27
App
1
Countries / Regions
India
371
Global
247
Sierra Leone
215
Liberia
202
Kenya
200
Nigeria
169
South Africa
162
Western and Central Europe
150
Ethiopia
144
Congo, Democratic Republic of
140
Africa
137
Uganda
130
Latin America and the Carribbean
129
Nepal
126
Rwanda
115
Tanzania
105
Senegal
103
Guinea
94
Malawi
89
Ghana
88
Zambia
88
West and Central Africa
79
Bangladesh
76
Russia
76
Burkina Faso
72
Syria
68
Brazil
67
Germany
65
Myanmar / Burma
65
East and Southern Africa
64
Namibia
64
Middle East and North Africa
63
Mozambique
58
Philippines
56
Haiti
55
Eastern Europe
55
Ukraine
53
Zimbabwe
51
South–East Asia Region
51
South Sudan
47
Côte d’Ivoire / Ivory Coast
46
Cameroon
43
Mali
43
Lesotho
42
Colombia
39
Cambodia
37
Asia
37
Benin
36
Eastern Europe and Central Asia
34
Yemen
33
Madagascar
33
Angola
30
Indonesia
30
Venezuela
27
Niger
25
Guinea-Bissau
21
Argentina
21
Central African Republic
21
Botswana
21
Eswatini/ Swaziland
21
Pakistan
21
Bolivia
20
Chad
20
USA
18
Western Pacific Region
18
Peru
17
Paraguay
17
Afghanistan
16
Spain
16
Vietnam
14
Somalia
14
Tajikistan
13
Sudan
13
Ecuador
13
Albania
12
Togo
11
China
11
Chile
10
Thailand
9
Jordan
9
Lebanon
9
Iraq
9
Georgia
8
El Salvador
7
Laos
7
Burundi
7
Italy
7
Saudi Arabia
7
United Kingdom
7
Moldova
7
North Macedonia
6
Timor Leste/ East Timor
6
Iran
6
France
6
Portugal
6
Papua New Guinea
6
Palestine
6
Mexico
5
Armenia
5
Sri Lanka
5
Bhutan
5
Serbia
4
Turkey
4
Congo-Brazzaville
4
North America
4
Turkmenistan
4
Southern Africa
4
Djibouti
4
Honduras
4
Libya
4
Switzerland
3
Gambia
3
Fiji
3
Singapore
3
Malaysia
3
Morocco
3
Ireland
3
Japan
3
Belgium
3
Mauritius
3
Egypt
3
Romania
3
Canada
2
Estonia
2
Kyrgyzstan
2
Uzbekistan
2
Qatar
2
Bulgaria
2
Dominican Republic
2
Gabon
2
Uruguay
2
Tunisia
2
Poland
2
North Korea
1
Australia
1
Kazakhstan
1
Austria
1
Mongolia
1
Cape Verde
1
Croatia
1
Hungary
1
Luxembourg
1
Denmark
1
Maldives
1
Morocco
1
Azerbaijan
1
Belarus
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Nicaragua
1
Slovakia
1
Greece
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2979
Clinical Guidelines
732
Key Resources
336
Women & Child Health
325
Public Health
320
Capacity Building
143
Pharmacy & Technologies
104
Annual Report MEDBOX
2
Toolboxes
COVID-19
1305
HIV
720
TB
617
Ebola
475
AMR
373
Rapid Response
344
NTDs
284
Caregiver
219
Mental Health
192
Planetary Health
157
Zika
127
Refugee
114
Pharmacy
110
Conflict
103
Cholera
90
NCDs
86
Disability
71
Global Health Education
69
Natural Hazards
52
Polio
47
Specific Hazards
28
Health Financing Toolbox
27
Social Ethics
5
South Sudan
2
Typhoon
1
La Profilaxis Post-Exposición para el VIH (PEP) constituye una herramienta de prevención que consiste en el uso de medicamentos antiretrovirales para reducir el riesgo de infección luego de situaciones de potencial exposición del virus. Su incorporación está recomendada por la Organización Mu...
Resumen para Equipos de Salud Edición 2021-2022
Las presentes recomendaciones se encuentran dirigidas a los miembros del equipo de salud que asisten niñas, niños y adolescentes (NNyA) que viven con VIH. También se dirigen a los responsables jurisdiccionales que participan en el proceso de gesti...
Final Report
Las personas infectadas por el virus de la inmunodeficiencia humana (VIH) tienen
29 veces más probabilidades de enfermar de tuberculosis (TB) que las personas
sin VIH que viven en el mismo país. La TB es una de las principales causas de muerte entre las personas infectadas por el VIH: provoca ...
The LDHS provides an opportunity to inform policy and provide data for planning, implementation, and monitoring and evaluation of national health programs. It is designed to provide up-to-date information on health indicators including fertility levels, sexual activity, fertility preferences, awaren...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
This manual is to assist health care providers and laboratory scientists to diagnose mycobacterium ulcerans disease (Buruli ulcer). The manual aims to achieve a better understanding of the clinical presentation and its diagnosis. The methods described are tailored to various levels of care and avail...
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
A qualitative assessment of knowledge gaps about female genital schistosomiasis among communities living in Schistosoma haematobium endemic districts of Zanzibar and Northwestern Tanzania.
PloS Neglected Tropical Diseases September 30, 2021 https://doi.org/10.1371/journal.pntd.0009789
Schistosoma...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
Onchocerciasis causes skin and eye disease, visual impairment and neurological problems. It is mostly found in Africa, but also in Latin America and Yemen. The common name, ‘river blindness,’ gives a good indication where the disease can be found: the vector of the parasite, a small black fly of...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
